What if you could find out about dozens of diseases, all at once, from just one tube of your blood?  It might happen soon, with proteomics and the search for wellness chip.   In this episode, we talk with scientists at Boulder’s Somalogic, Dan Chan, developer of the proteomics based OVA-1 ovarian cancer test, Quest Diagnostic VP of Business Development Nick Conti, and Stanford Geneticist Mike Snyder (for an extended version of the interview with Mike Snyder, click here).  Special thanks also to Boulder playwright Len Barron for reading the poem, The Blind Men and the Elephant.

Hosts: Joel Parker and Breanna Draxler